Trials / Sponsors / Shanghai Pharma Biotherapeutics USA Inc.
Shanghai Pharma Biotherapeutics USA Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas Liposarcoma, Dedifferentiated | Phase 2 | 2023-08-31 |
| Terminated | Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2022-03-21 |